Email this page
Print
Bookmark and share
Bigger
Smaller
Download PDF
RSS feedFor consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS RADAR April 2007NPS RADAR April 2007
NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.
Find out more about NPS RADAR.
| Title | Why read this |
|---|---|
| NPS RADAR April 2007 Professional publication - NPS RADAR - Complete issue | NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals. |
| Ciprofloxacin ear drops (Ciloxan) for chronic suppurative otitis media in Aboriginal and Torres Strait Islander people Professional publication - NPS RADAR - Brief item | Ciprofloxacin ear drops (Ciloxan) were listed on the PBS to allow prescribing for chronic suppurative otitis media (CSOM) in Aboriginal and Torres Strait Islander people. |
| Sildenafil (Revatio) listed for pulmonary hypertension Professional publication - NPS RADAR - Brief item | Sildenafil (Revatio) was PBS listed as a Section 100 hospital Authority-required item for the treatment of primary pulmonary hypertension or pulmonary hypertension associated with connective tissue disease in patients categorised as WHO functional class III. |
| Trandolapril 4 mg with verapamil sustained-release 240 mg fixed-dose combination tablet (Tarka) to be listed on PBS Professional publication - NPS RADAR - Brief item | Trandolapril 4 mg with verapamil sustained release 240 mg fixed-dose combination tablet (Tarka) will be listed on the PBS for people already stabilised on antihypertensive treatment who wish to reduce the number of tablets they take each day. |
| Medicine Update: the new consumer version of NPS RADAR Professional publication - NPS RADAR - Brief item | Medicine Update, a new publication from NPS, will review newly listed PBS medicines for a consumer audience, with a quality use of medicines focus, and will be available on-line from the NPS website. |
| Alendronate (Alendro Once Weekly, Fosamax Once Weekly, Fosamax Plus) for osteoporosis in people at high risk of fracture Professional publication - NPS RADAR - Review | Reviews extension of PBS listing for alendronate to include treatment of osteoporosis without fracture in older people with low bone mineral density scores. |
| Methylphenidate extended-release (Concerta) for attention deficit hyperactivity disorder (ADHD) Professional publication - NPS RADAR - Review | Reviews use of extended-release methylphenidate, including comparison with immediate-release formulation and risk of cardiovascular adverse effects. |
| Additional content - Extended-release methylphenidate (Concerta) for attention deficit hyperactivity disorder Professional publication - NPS RADAR - Web only item |
Complete list of all NPS RADAR content.
Find out more about NPS RADAR.
Date published: 2007-04-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
